T2 Hyperintense Lesions on Breast MRI – Is the Assumption of Benignity Justified?
Canadian Association of Radiologists Journal · 2026
DOI: 10.1177/08465371251346137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Association of Radiologists Journal, 2026. Verfasst von Yulia Nechyporenko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Image-Guided Biopsy, Magnetic Resonance Imaging, Interventional. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This study aims to evaluate the outcomes of breast MRI-guided vacuum assisted biopsies (MVAB) performed on lesions with high T2 signal. Materials and Methods: We retrospectively collected of all MVAB performed at our institution between January 2016 and December 2021 for high T2 lesions. T2 hyperintensity was defined as equal or higher signal than normal lymph node. The correlation between various demographic and imaging characteristics and the binary pathological outcome (benign vs malignant) was evaluated.
Results
In total, 174 biopsies from 165 women met the inclusion criteria and were included in the cohort. Malignancy was detected in 35 lesions (20%), most commonly ductal carcinoma in situ (DCIS, 57%), followed by infiltrating ductal carcinoma (IDC, 40%). The most common benign diagnosis was fibrocystic changes (FCC, 38%). In 19 lesions MVAB detected high-risk pathology, 3 of which were upgraded to malignancy. Older age (Mean 61 vs 54 years, P = .04), washout kinetics (29% vs 13%, P = .01), and indication for extent of disease evaluation (53% vs 32%, P = .06) were the strongest predictors of malignancy. Lesion size and morphology were not significantly associated with outcome.
Conclusions
Given the considerable cancer rate, T2 hyperintensity should be used with caution as a benign indicator and not as a sole criterion for ruling out malignancy. Additional factors such as patient age, kinetic features, and MRI indication should be considered to improve diagnostic accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Surgery, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel.
- Joint Department of Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Vivianne A R Freitas, Rina Neeman, Yoav Amitai
Zitieren
APA
Nechyporenko, Y., Golan, O., Menes, T. S., Freitas, V. A. R., Kessner, R., Neeman, R., Mauda-Havakuk, M., Broitman, S., Stav, D., Lazar, S., Mercer, D., & Amitai, Y. (2026). T2 Hyperintense Lesions on Breast MRI – Is the Assumption of Benignity Justified?. Canadian Association of Radiologists Journal. https://doi.org/10.1177/08465371251346137
Vancouver
Nechyporenko Y, Golan O, Menes TS, Freitas VAR, Kessner R, Neeman R, et al. T2 Hyperintense Lesions on Breast MRI – Is the Assumption of Benignity Justified?. Canadian Association of Radiologists Journal. 2026. doi:10.1177/08465371251346137
BibTeX
@article{Nechyporenko2026,
author = {Nechyporenko, Yulia and Golan, Orit and Menes, Tehillah S and Freitas, Vivianne A R and Kessner, Rivka and Neeman, Rina and Mauda-Havakuk, Michal and Broitman, Shani and Stav, Dana and Lazar, Sapir and Mercer, Diego and Amitai, Yoav},
title = {T2 Hyperintense Lesions on Breast MRI – Is the Assumption of Benignity Justified?},
journal = {Canadian Association of Radiologists Journal},
year = {2026},
doi = {10.1177/08465371251346137}
}
EUVIMED